Guangxi Wuzhou Zhongheng Group Co., Ltd.SSE: 600252

Report for Q1 2026

Apr 30, 2026 · Issued by Guangxi Wuzhou Zhongheng Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 30, 2026

On 6ix: 6ix.com/news/report-for-q1-2026-30

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Guangxi Wuzhou Zhongheng Group Co., Ltd. on 6ix

Earlier from Guangxi Wuzhou Zhongheng

Announcement on Resolutions of the 2025 Annual General MeetingApr 29
Announcement on Completion of Liquidation and Deregistration of Guangxi Lihe Zhongheng Pharmaceutical Investment Partnership (Limited Partnership)Apr 23
Announcement on Progress in Government Land Reserve of the Land of Controlling Sub-subsidiaryApr 2
Announcement on Resignation of Directors and Financial Person in Charge and the Election of Employee Representative DirectorsApr 1
Notice on Convening the 2025 Annual General MeetingMar 31

Later from Guangxi Wuzhou Zhongheng

Announcement on Convening the 2025 Annual Performance BriefingMay 9
Announcement on Completion of Private Investment Fund Filing by the Venture Capital Fund Established with Investment Participation of the Holding SubsidiaryMay 12
Announcement on Holding Sub-subsidiary Obtaining Approval for Marketing of Chemical APIsMay 16
Notice on Convening the 1st Extraordinary General Meeting in 2026May 20
Announcement on Completing Deregistration of Zhongheng Group Wuzhou Pharmaceutical (Hong Kong) Co., Ltd.May 21

All Guangxi Wuzhou Zhongheng news releases

Follow Guangxi Wuzhou Zhongheng into a list and get an email when it puts out news.

Follow Guangxi Wuzhou Zhongheng